Sagent Pharmaceuticals Announces Amendment to Supply Agreement With Actavis, Inc.

[at noodls] – SCHAUMBURG, Ill., March 5, 2013 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader in specialty injectable pharmaceutical products, today announced the signing of an amendment to … more

View todays social media effects on SGNT

View the latest stocks trending across Twitter. Click to view dashboard

See who Sagent is hiring next, click here to view